AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

96,100

Employees96,100

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

96,100

Employees96,100

AZN Key Statistics

Market cap

245.51B

Market cap245.51B

Price-Earnings ratio

23.50

Price-Earnings ratio23.50

Dividend yield

1.68%

Dividend yield1.68%

Average volume

2.72M

Average volume2.72M

High today

$162.06

High today$162.06

Low today

$161.99

Low today$161.99

Open price

$159.46

Open price$159.46

Volume

30.33K

Volume30.33K

52 Week high

$212.71

52 Week high$212.71

52 Week low

$153.41

52 Week low$153.41

Stock Snapshot

The current AstraZeneca(AZN) stock price is $161.99, with a market capitalization of 245.51B. The stock trades at a price-to-earnings (P/E) ratio of 23.50 and offers a dividend yield of 1.68%.

As of 2026-10-13, AstraZeneca(AZN) stock has fluctuated between $161.99 and $162.06. The current price stands at $161.99, placing the stock 0.0% above today's low and -0.0% off the high.

The AstraZeneca(AZN)'s current trading volume is 30.33K, compared to an average daily volume of 2.72M.

In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.

AZN News

TipRanks 2h

AstraZeneca upgraded to Buy from Sell at Nordea

Nordea double upgraded AstraZeneca (AZN) to Buy from Sell with a price target of SEK 1,900, up from SEK 1,650. The firm sees investor focus returning to the com...

Benzinga 22h

AstraZeneca Says Rare Disease Drug Shows Improvements in Inherited Bone Disorder Despite Missing Key Trial Goal - Benzinga

...

TipRanks 5d

AstraZeneca’s Kazakhstan Breast Cancer Study: Real‑World Data With Quiet but Important Signals for AZN

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a new real‑world study in Kazakhstan to track how doctors...

Analyst ratings

90%

of 10 ratings

Buy

90%

Hold

Sell

10%

More AZN News

TipRanks 5d

AstraZeneca’s Liver Cancer Trial Completion: What It Means for AZN Investors

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca’s latest update covers a Phase III trial in liver cancer that tests whethe...

Zacks 7d

Astrazeneca Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Astrazeneca (AZN Quick QuoteAZN - Free Report) closed at $158.61, marking a +1.33% move from the previous day. The stock ou...

TipRanks 7d

AstraZeneca’s Real World COPD Study in Russia Signals Strategic Respiratory Focus

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is backing a real world COPD study that tracks patients in Russia who...

TipRanks 7d

AstraZeneca Targets COPD Care Efficiency With Hospital Level Transition Bundle Study

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca has completed a clinical study titled “Boosting Regional Integration for C...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.